Panbela Therapeutics Inc. (PBLA) poses a Brand-New Opportunity for Investors with beta value of 0.82
Panbela Therapeutics Inc. (NASDAQ: PBLA) open the trading on Wednesday, with a bit cautious approach as it glided -9.76% to $1.11, before settling in for